RSCM
ICVX

Rock Springs Capital Management’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Rock Springs Capital Management’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-868,409
Closed -$13.7M – 118
2023
Q4 		$13.7M Hold
868,409
– – 0.34% 66
2023
Q3 		$6.73M Hold
868,409
– – 0.18% 79
2023
Q2 		$8.62M Buy
868,409
+3,899
+0.5% +$31.2K 0.21% 79
2023
Q1 		$5.01M Buy
864,510
+83,510
+11% +$721K 0.12% 87
2022
Q4 		$6.2M Hold
781,000
– – 0.15% 80
2022
Q3 		$2.47M Buy
781,000
+19,443
+3% +$122K 0.06% 109
2022
Q2 		$4.36M Hold
761,557
– – 0.13% 97
2022
Q1 		$5.36M Buy
761,557
+26,053
+4% +$410K 0.13% 101
2021
Q4 		$16.8M Buy
735,504
+1,289
+0.2% +$33.3K 0.39% 74
2021
Q3 		$21.7M Buy
+734,215
New +$24.9M 0.46% 69

Rock Springs Capital Management's ICVX Position: Q1 2024 in Review

Rock Springs Capital Management sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 868,409 shares — an estimated $13.7M sold.

Rock Springs Capital Management first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $21.7M in Q3 2021. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • Rock Springs Capital Management reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Rock Springs Capital Management sold 868,409 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $13.7M.
  • Rock Springs Capital Management first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • Rock Springs Capital Management's Icosavax, Inc. Common Stock position peaked at $21.7M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Rock Springs Capital Management's 13F filing for Q1 2024, filed 15 May 2024.